Advertisement

Superficial Fungal Infections

  • Mohamed Taha
  • Adel Botros Zaghloul
Chapter

Abstract

Fungal infections of the skin and nails are the most common and widespread group of all mycoses; they affect more than 20–25% of the world’s population [1]. The incidence of cutaneous mycoses continues to increase, particularly in tropical countries because of the heat and humidity, whereas the prevalence of the causative species of fungi involved has shifted or changed due to migration and changes in socioeconomic status and lifestyle [2]. People with colored skin, especially deeply pigmented or black-skinned populations, show high frequency of superficial mycosis, which may reach up to 41.9% of all dermatoses seen, as has been reported from West Africa [3]; they are frequently registered also in tourists and travelers. The clinical pictures can be subdivided into infections that induce minimal or no inflammatory response, e.g., pityriasis versicolor, tinea nigra, or piedra, and those that induce cutaneous inflammation such as cutaneous candidosis and tinea.

References

  1. 1.
    Havlickova B, Cziaka C, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51:412–5.Google Scholar
  2. 2.
    Ameen M. Epidemiology of superficial fungal infections. Clin Dermatol. 2010;28:197–201.CrossRefGoogle Scholar
  3. 3.
    Bari AU, Khan MB. Pattern of skin diseases in black Africans of Sierra Leone, West Africa. J Clin Diagn Res. 2007;5:361–8.Google Scholar
  4. 4.
    Heidrich D, Daboit TC, Stopiglla CD, et al. Sixteen years of pityriasis versicolor in metropolitan area of Porto Alegre, Southern Brazil. Rev Inst Med Trop Sao Paulo. 2015;57:277–80.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kallini JR, Raiz F, Klachemoune A. Tinea versicolor in dark-skinned individuals. Int J Dermatol. 2014;53:137–41.CrossRefPubMedGoogle Scholar
  6. 6.
    Crespo-Erchiga V, Ojeda Marios A, Vera Casano A, et al. Malassezia globosa as the causative agent of pityriasis versicolor. Br J Dermatol. 2000;143:799–804.CrossRefPubMedGoogle Scholar
  7. 7.
    Gaitanis G, Velegraki A, Alexopoulos EC, et al. Distribution of Malassezia species in pityriasis versicolor and seborrhoeic dermatitis in Greece. Typing of the major pityriasis versicolor isolate M. globosa. Br J Dermatol. 2006;154:854–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Gupta AK, Kohli Y, Faergemann J, et al. Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada. Med Mycol. 2001;39:199–206.CrossRefPubMedGoogle Scholar
  9. 9.
    Ghahfarokhi MS, Abyaneh MR. Rapid identification of Malassezia furfur from other Malassezia species. A major causative agent of pityriasis versicolor. Iran J Med Sci. 2004;29:36–9.Google Scholar
  10. 10.
    Khafagy A, El Fangary M, Shahin M, et al. Identification of Malassezia species isolated from pityriasis versicolor patients. Egypt J Dermatol Vener. 2006;26:9–14.Google Scholar
  11. 11.
    Velegraki A, Cafarchia C, Gaitanis G, et al. Malassezia infections in humans and animals: pathophysiology, detection, and treatment. PLoS Pathog. 2015;11:e1004523.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Mayser PA, Preuss J. Pityriasis versicolor: Aktuelles zu einer alten Erkrankung. Hautarzt. 2012;63:359–67.CrossRefGoogle Scholar
  13. 13.
    Martin ES, Elwski BE. Cutaneous fungal infections in the elderly. Clin Geriatr Med. 2002;18:59–75.CrossRefPubMedGoogle Scholar
  14. 14.
    Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4:119–28.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Cornet M, Sendid B, Fradin C, et al. Molecular identification of closely related Candida species using two ribosomal intergenic spacer fingerprinting methods. J Mol Diagn. 2011;13:12–22.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Stevenson LG, Drake SK, Shea YR, et al. Evaluation of matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF) for identification of clinically important yeast species. J Clin Microbiol. 2010;48:3482–6.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Nenoff P, Krüger C, Paasch U, et al. Mycology—an update part 3: dermatomycosis: topical and systemic therapy. J Dtsch Dermatol Ges. 2015;13:387–410.PubMedGoogle Scholar
  18. 18.
    Ali R. Ecology and epidemiology of dermatophyte infections. J Am Acad Dermatol. 1994;31:S21–5.CrossRefGoogle Scholar
  19. 19.
    Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophytes. Mycopathologia. 2008;166:335–52.CrossRefPubMedGoogle Scholar
  20. 20.
    Nenoff P, Kruger C, Ginter-Hanselmayer C, et al. Mycology—an update, Part 1: dermatomycosis: causative agents, epidemiology and pathogenesis. J Dtsch Dermatol Ges. 2014;12:764–77.Google Scholar
  21. 21.
    Zhu M, Li L, Wang J, et al. Tinea capitis in Southeastern China: a 16-year survey. Mycopathologia. 2010;169:235–9.CrossRefGoogle Scholar
  22. 22.
    El Fangary M, Saudy W, Nabil T, et al. Prevalence of dermatophytes, yeasts, non dermatophyte moulds isolated from skin, hair, and nail fungal infections in the 6th October City-Giza Egypt. Egypt J Dermatol Venerol. 2011;31:5–10.Google Scholar
  23. 23.
    Wildemanual Y, Lekassu R, Chryssanthou E, et al. Prevalence of tinea capitis in Ethiopian school children. Mycoses. 2005;48:137–41.CrossRefGoogle Scholar
  24. 24.
    Faure-Cognet O, Fricker-Hidalgo H, Pelloux H, et al. Superficial fungal infections in a French teaching hospital in Grenoble area: retrospective study on 5470 samples from 2001 to 2011. Mycopathologia. 2016;181:59–66.CrossRefPubMedGoogle Scholar
  25. 25.
    Seebacher C, Abeck D, Brasch J, et al. Tinea capitis. J Dtsch Dermatol Ges. 2006;12:1085–91.CrossRefGoogle Scholar
  26. 26.
    Bonifaz A, Archer-Dubon A, Saul A. Tinea imbricata or Tokelau. Int J Dermatol. 2004;43:506–10.CrossRefPubMedGoogle Scholar
  27. 27.
    Dias MF, Quaresma-Santos MV, Bernardes-Filho F, et al. Update on therapy for superficial mycoses. An Bras Dermatol. 2013;88:764–74.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Chen X, Jiang X, Yang M et al. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2016;(5):CD004685.Google Scholar
  29. 29.
    Severo LC, Bassanesi MC, Londero AT. Tinea nigra: report of four cases observed in Rio Grande do Sul (Brazil) and a review of Brazilian literature. Mycopathologia. 1994;126:157–62.CrossRefPubMedGoogle Scholar
  30. 30.
    Perez C, Colella MT, Olaizola C, et al. Tinea nigra: report of twelve cases in Venezuela. Mycopathologia. 2005;160:235–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Uezato H, Gushi M, Hagiwara K, et al. A case of tinea nigra palmaris in Okinawa, Japan. J Dermatol. 2006;33:23–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Rezusta A, Gilaberte Y, Betran A, et al. Tinea nigra: a rare imported infection. J Eur Acad Dermatol Venereol. 2010;24:89–91.CrossRefPubMedGoogle Scholar
  33. 33.
    Pegas JR, Crado PR, Lucena SK. Tinea nigra: report of two cases in infants. Pediatr Dermatol. 2003;20:315–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Elsayed A, Mowafy AM, Soliman HM, et al. Characterization of new strains of Hortaea werneckii isolated from salt marshes of Egypt. J Basic Appl Sci. 2016;3:350–6.Google Scholar
  35. 35.
    Maia Abinader MV, Cavalh Maron CM, Araújo LO, et al. Tinea nigra dermoscopy: a useful assessment. J Am Acad Dermatol. 2016;74:121–2.CrossRefGoogle Scholar
  36. 36.
    Bonifaz A, Badali H, de Hoog GS, et al. Tinea nigra by Hortaea werneckii, a report of 22 cases from Mexico. Stud Mycol. 2008;61:77–82.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Summerbell RC, Cooper E, Bunn U, et al. Onychomycosis: a critical study of techniques and criteria for confirming the etiologic significance of non dermatophytes. Med Mycol. 2005;43:39–59.CrossRefPubMedGoogle Scholar
  38. 38.
    Nenoff P, Ginter-Hanselmayer G, Tietz HJ. Fungal nail infections—an update: part I—prevalence, epidemiology, predisposing conditions and differential diagnosis. Hautarzt. 2012;63:30–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Martínez-Herrera EO, Arroyo-Camarena S, Tejada-García DL, et al. Onychomycosis due to opportunistic moulds. An Bras Dermatol. 2015;90:334–7.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Baran R, Hay RJ, Tosti A, et al. A new classification of onychomycosis. Br J Dermatol. 1998;139:567–71.CrossRefPubMedGoogle Scholar
  41. 41.
    Gupta AK, Scher RK. Management of onychomycosis an North American perspective. Dermatol Ther. 1997;3:58–65.Google Scholar
  42. 42.
    Roberts DT, Taylor WD, Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol. 2003;48:402–10.CrossRefGoogle Scholar
  43. 43.
    Gupta AK, Simpson FC. New therapeutic options for onychomycosis. Expert Opin Pharmacother. 2012;13:1131–42.CrossRefPubMedGoogle Scholar
  44. 44.
    Cortes A, Orfanos CE. Piedra. In: Orfanos CE, Happle R, editors. Hair and hair diseases. Heidelberg: Springer; 1999. p. 745–9.Google Scholar
  45. 45.
    Kalter DC, Tachen JA, Cernoch PL, et al. Genital piedra: epidemiology, microbiology and therapy. J Am Acad Dermatol. 1986;14:982–93.CrossRefPubMedGoogle Scholar
  46. 46.
    Rios X, Rojas RF, Hincapi ML. Eight white piedra pediatric cases. Rev Assoc Colomb Dermatol. 2012;20:175–80.Google Scholar
  47. 47.
    Combra CE, Santos RV. Black piedra among the Zoró Indians from Amazônia (Brazil). Mycopathologia. 1989;107:57–60.CrossRefGoogle Scholar
  48. 48.
    Khatu SS, Poojary SA, Nagpur NG. Nodules on the hair: a rare case of mixed piedra. Int J Trichol. 2013;5:220–3.CrossRefGoogle Scholar
  49. 49.
    Gip L. Black piedra: the first case treated with terbinafine (Lamisil). Br J Dermatol. 1994;130:26–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Mohamed Taha
    • 1
  • Adel Botros Zaghloul
    • 2
  1. 1.Department of MicrobiologyZagazig UniversityZagazigEgypt
  2. 2.Cairo Skin Clinic, VD HospitalCairoEgypt

Personalised recommendations